After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Jade Biosciences Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Jade Biosciences Inc is $8.67M. A total of 0.89 million shares were traded on the day, compared to an average of 225.22K shares.
In the most recent transaction, Frohlich Tom bought 6,000 shares of JBIO for 7.40 per share on May 16 ’25. After the transaction, the Chief Executive Officer now owns 6,000 company shares. In a previous transaction on May 06 ’25, Atlas Venture Associates XII, bought 48 shares at 11.50 per share.
Among the insiders who bought shares, Atlas Venture Fund XII, L.P. acquired of 5,883 shares on May 06 ’25 at a per-share price of $11.50.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, JBIO has a high of $13.50 and a low of $4.57.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JBIO is Buy with a score of 5.00.
